Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
22.2M
-
Number of holders
-
112
-
Total 13F shares, excl. options
-
9.6M
-
Shares change
-
+260K
-
Total reported value, excl. options
-
$1.01B
-
Value change
-
+$18.5M
-
Put/Call ratio
-
1.15
-
Number of buys
-
67
-
Number of sells
-
-45
-
Price
-
$104.81
Significant Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) as of Q2 2019
160 filings reported holding MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock as of Q2 2019.
MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) has 112 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.6M shares
of 22.2M outstanding shares and own 43.24% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (1.68M shares), BAKER BROS. ADVISORS LP (1.17M shares), HealthCor Management, L.P. (1.03M shares), VANGUARD GROUP INC (751K shares), STATE STREET CORP (618K shares), BlackRock Inc. (562K shares), ARMISTICE CAPITAL, LLC (408K shares), Avoro Capital Advisors LLC (360K shares), ALLIANCEBERNSTEIN L.P. (327K shares), and JENNISON ASSOCIATES LLC (305K shares).
This table shows the top 112 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.